Compugen (CGEN) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Compugen (CGEN) over the last 15 years, with Q3 2025 value amounting to $97.8 million.
- Compugen's Liabilities and Shareholders Equity fell 2078.35% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $434.8 million, marking a year-over-year decrease of 723.48%. This contributed to the annual value of $115.0 million for FY2024, which is 522.44% down from last year.
- As of Q3 2025, Compugen's Liabilities and Shareholders Equity stood at $97.8 million, which was down 2078.35% from $106.5 million recorded in Q2 2025.
- Compugen's 5-year Liabilities and Shareholders Equity high stood at $130.0 million for Q1 2021, and its period low was $67.6 million during Q3 2023.
- In the last 5 years, Compugen's Liabilities and Shareholders Equity had a median value of $112.0 million in 2022 and averaged $107.3 million.
- In the last 5 years, Compugen's Liabilities and Shareholders Equity crashed by 3195.83% in 2023 and then soared by 8268.62% in 2024.
- Compugen's Liabilities and Shareholders Equity (Quarter) stood at $121.3 million in 2021, then dropped by 22.36% to $94.2 million in 2022, then increased by 28.84% to $121.3 million in 2023, then dropped by 5.22% to $115.0 million in 2024, then fell by 14.91% to $97.8 million in 2025.
- Its Liabilities and Shareholders Equity was $97.8 million in Q3 2025, compared to $106.5 million in Q2 2025 and $115.4 million in Q1 2025.